Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1161520230270010103
Animal Cells and Systems
2023 Volume.27 No. 1 p.103 ~ p.111
Association of overexpressed carboxyl-terminal amyloid precursor protein in brains with altered glucose metabolism and liver toxicity
Hong Sung-Guan

Hong Seung-Woo
Lee Sung-Hoon
Abstract
Alzheimer¡¯s disease (AD) is the most prevalent neurodegenerative disease. The deposition of amyloid plaques mainly composed of amyloid beta (A¥â) is observed in brain regions in AD patients. AD presents with similar pathophysiology to that of metabolic syndrome, including glucose and insulin resistance. In addition, epidemiological studies indicate diabetes, impaired glucose metabolism, and obesity increase the prevalence of AD. The liver is considered a key organ in the reciprocal relationship between AD and metabolic syndrome and is the major organ for the clearance of A¥â in the periphery. Furthermore, liver dysfunction aggravates A¥â-induced pathophysiology. A¥â is produced in the brain and peripheral tissues and penetrates the blood?brain barrier. However, in vivo evidence showing the effect of A¥â on the crosstalk between the brain and liver has not been reported yet. In the present study, we investigated the toxicity of brain-derived A¥â on glucose metabolism and the liver using transgenic mice overexpressing the carboxyl-terminal of amyloid precursor protein in the brain. The transgenic mice were overweight, which was associated with impaired glucose metabolism and insulin resistance, but not due to increased food intake. In addition, transgenic mice had enlarged livers and reduced gene expressions associated with glucose and lipid metabolism. Thus, overexpressed amyloid precursor protein in the brain may promote being overweight and glucose resistance, possibly through liver toxicity.
KEYWORD
Carboxyl-terminal of amyloid precursor protein, liver, insulin/glucose tolerance, glucose and lipid metabolism-related genes, in vivo
FullTexts / Linksout information
Listed journal information